Explore News By Topic
Breast Cancer Research Foundation and Prostate Cancer Foundation Announce Their Commitment to Support the Blood Profiling Atlas in Cancer
In alignment with VP Biden’s Cancer Moonshot initiative, the Blood PAC formed in October 2016 to support progress towards patient benefit through research.
The Prostate Cancer Foundation (PCF) applauds Congress and the White House for the strong, bipartisan show of support for the 21st Century Cures Act (H.R. 34). Following the Senate’s passage by a vote of 94 to 5, Congressional leaders signed the bill at this morning’s Enrollment Ceremony. The House had previously passed the game-changing medical innovation.
Holiday Cards Commemorating Musician Dan Fogelberg Now Available Sales Will Benefit The Prostate Cancer Foundation
PR Newswire, SANTA MONICA, CA December 1, 2016 The Prostate Cancer Foundation (PCF) announces that holiday cards designed by Jean Fogelberg in memory of her husband, musician Dan Fogelberg, are now available for purchase. Fogelberg passed away from prostate cancer in 2007 at the age of 56. A portion of.
Prostate cancer is one of the most heritable forms of cancer. Hereditary mutations in “DNA repair” genes – BRCA1, BRCA2, and others – which are best known for their association with breast and ovarian cancer predisposition, are now known to be associated with advanced prostate cancer. In fact, ~12% of.
An overactive gene appears to cause some prostate cancers to transform from a typical tumor type to a much more aggressive form of the disease, according to new research at Weill Cornell Medicine. The Prostate Cancer Foundation supported the study through a Janssen-PCF Challenge Award, which funds research conducted by.
The Prostate Cancer Foundation celebrates the life and legacy of our friend, golf icon Arnold Palmer, who passed away on September 25, 2016. A legend in the truest sense of the word, he possessed a unique charisma that transcended his performance on the fairway. There is no question that Mr..
The Prostate Cancer Foundation’s 2016 Coffey-Holden Prostate Cancer Academy Meeting Accelerates Advances In The Understanding And Treatment Of Metastatic Prostate Cancer
The Prostate Cancer Foundation (PCF) has a legacy of not only funding the most impactful research in prostate cancer, but also creating new infrastructures, global knowledge networks, and research initiatives that support and accelerate prostate cancer research towards better treatment for advanced prostate cancer patients. For the past four years,.
Prostate Cancer Foundation Receives More Than $5 Million from the Movember Foundation 5 New Challenge Awards will Fund Investigations in Lethal Prostate Cancer SANTA MONICA, CA August 2, 2016 -- The Prostate Cancer Foundation (PCF) announces 5 new Movember Foundation-PCF Challenge Awards to advance new treatments and cures for metastatic,.
Feb. 24, 2015 (HealthDay News) -- U.S. recommendations against the PSA test for prostate cancer might have prompted a small but measurable increase in the number of higher-risk cases diagnosed recently, according to a new study. The U.S. Preventive Services Task Force (USPSTF) in 2009 recommended that the PSA test.